| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |